2021
Perceived Limits of Endovascular Treatment for Secondary Medium-Vessel-Occlusion Stroke
CIMFLOVÁ, Petra, R. MCDONOUGH, M. KAPPELHOF, N. SINGH, N. KASHANI et. al.Základní údaje
Originální název
Perceived Limits of Endovascular Treatment for Secondary Medium-Vessel-Occlusion Stroke
Autoři
CIMFLOVÁ, Petra (203 Česká republika, domácí), R. MCDONOUGH, M. KAPPELHOF, N. SINGH, N. KASHANI, J. M. OSPEL, A. M. DEMCHUK, B. K. MENON, M. CHEN, N. SAKAI, J. FIEHLER a M. GOYAL (garant)
Vydání
American Journal of Neuroradiology, Denville, American Society of Neuroradiology, 2021, 0195-6108
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30224 Radiology, nuclear medicine and medical imaging
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 4.966
Kód RIV
RIV/00216224:14110/21:00124155
Organizační jednotka
Lékařská fakulta
UT WoS
000711963300001
Klíčová slova anglicky
Endovascular Treatment; Secondary Medium-Vessel-Occlusion Stroke
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 15. 2. 2022 10:03, Mgr. Tereza Miškechová
Anotace
V originále
BACKGROUND AND PURPOSE: Thrombus embolization during mechanical thrombectomy occurs in up to 9% of cases, making secondary medium vessel occlusions of particular interest to neurointerventionalists. We sought to gain insight into the current endovascular treatment approaches for secondary medium vessel occlusion stroke in an international case-based survey because there are currently no clear recommendations for endovascular treatment in these patients. MATERIALS AND METHODS: Survey participants were presented with 3 cases involving secondary medium vessel occlusions, each consisting of 3 case vignettes with changes in the patient?s neurologic status (improvement, no change, unable to assess). Multivariable logistic regression analyses clustered by the respondent?s identity were used to assess factors influencing the decision to treat. RESULTS: In total, 366 physicians (56 women, 308 men, 2 undisclosed) from 44 countries provided 3294 responses to 9 scenarios. Most (54.1%, 1782/3294) were in favor of endovascular treatment. Participants were more likely to treat occlusions in the anterior M2/3 (74.3%; risk ratio = 2.62; 95% CI, 2.27?3.03) or A3 (59.7%; risk ratio = 2.11; 95% CI, 1.83?2.42) segment compared with the M3/4 segment (28.3%; reference). Physicians were less likely to pursue endovascular treatment in patients who showed neurologic improvement than in patients with an unchanged neurologic deficit (49.9% versus 57.0% responses in favor of endovascular treatment, respectively; risk ratio = 0.88, 95% CI, 0.83?0.92). Interventionalists and more experienced physicians were more likely to treat secondary medium vessel occlusions. CONCLUSIONS: Physicians? willingness to treat secondary medium vessel occlusions endovascularly is limited and varies per occlusion location and change in neurologic status. More evidence on the safety and efficacy of endovascular treatment for secondary medium vessel occlusion stroke is needed.